Active Ingredient History
Tenofovir alafenamide, sold under the brand name Vemlidy, is a hepatitis B virus (HBV) nucleotide reverse transcriptase inhibitor medication for the treatment of chronic hepatitis B virus (HBV) infection in adults with compensated liver disease. It is taken by mouth. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Combination drugs
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Alveolar Bone Loss (Phase 4)
Anesthesia and Analgesia (Early Phase 1)
Antiretroviral Therapy, Highly Active (Phase 4)
Art (Phase 4)
Arthritis (Phase 4)
Bone Diseases, Metabolic (Phase 4)
Buprenorphine (Phase 4)
Coinfection (Phase 4)
Coronary Artery Disease (Phase 4)
COVID-19 (Phase 3)
Drug Evaluation (Phase 4)
Drug Misuse (Phase 4)
Drugs, Investigational (Phase 4)
Fatigue (Phase 2)
Harm Reduction (Phase 4)
Health Personnel (Phase 3)
Healthy Volunteers (Phase 1)
Hepatitis B (Phase 4)
Hepatitis B, Chronic (Phase 4)
Hepatitis B virus (Phase 4)
Hepatitis C (Phase 4)
Hepatitis C, Chronic (Phase 4)
Hepatitis D, Chronic (Phase 2)
Herpes Simplex (Phase 1)
HIV (Phase 4)
HIV-1 (Phase 4)
HIV Seropositivity (Phase 3)
Hormones (Phase 4)
Immunosuppression Therapy (Phase 4)
Insulin Resistance (Phase 1)
Kidney Transplantation (Phase 4)
Leukemia, Lymphoid (Phase 2)
Liver Cirrhosis (Phase 4)
Liver Diseases (Phase 4)
Liver Failure (Phase 4)
Liver Transplantation (Phase 4)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Medication Adherence (Early Phase 1)
Menopause (Phase 4)
Methadone (Phase 4)
Multiple Sclerosis, Relapsing-Remitting (Phase 2)
Neoplasms (Phase 3)
Opioid-Related Disorders (Phase 4)
Osteoporosis (Phase 4)
Pregnancy (Phase 2)
Renal Insufficiency (Phase 4)
Renal Insufficiency, Chronic (Phase 4)
Safety (Phase 4)
Sexually Transmitted Diseases (Phase 4)
Tenofovir (Phase 4)
Tuberculosis (Phase 4)
Tuberculosis, Pulmonary (Phase 2)
Virus Diseases (Phase 4)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue